Human ZNF609 (aa 54-143) Control Fragment Recombinant Protein | Invitrogen RP-98149 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Invitrogen

other brands :

NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience

product type :

protein

product name :

Human ZNF609 (aa 54-143) Control Fragment Recombinant Protein

catalog :

RP-98149

quantity :

100 uL

price :

US 259.00

product information

Product Type :

Protein

Product Name :

Human ZNF609 (aa 54-143) Control Fragment Recombinant Protein

Catalog # :

RP-98149

Quantity :

100 uL

Price :

US 259.00

Clonality :

Recombinant

Purity :

purified

Reactivity :

Human

Applications :

Blocking Assay: Assay-dependent, Control: Assay-dependent

Species :

Human

Storage :

-20 C, Avoid Freeze/Thaw Cycles

Description :

The ZNF609 gene encodes zinc finger protein 609, which functions as a transcriptional regulator involved in the modulation of gene expression during development and cellular differentiation. ZNF609 contains zinc finger domains, which enable it to bind DNA and control the transcription of target genes, influencing processes such as cell proliferation and neuronal development. This gene is particularly important for normal neural and muscle cell function and has been implicated in neurodevelopmental disorders and cancer. ZNF609 is known to interact with signaling pathways that control neuron differentiation and migration, and alterations in its expression have been associated with conditions like intellectual disability and developmental delay. Furthermore, ZNF609's role in cancer biology shows its involvement in regulating genes linked to tumor progression and metastasis. Studies on ZNF609 focus on understanding its regulatory mechanisms and potential as a therapeutic target for diseases related to developmental deficits and cancer.

Format :

Liquid

Applications w/Dilutions :

Blocking Assay: Assay-dependent, Control: Assay-dependent

Aliases :

9830165N24; BC016271; Kiaa0295; mKIAA0295; RGD1561651; Zfp609; Zinc finger protein 609; zinc finger protein 609 pseudogene; Znf609